Occupational allergy to glucagon-like peptide-1 receptor agonist precurser

被引：0
|
作者：
Johnsen, C. R. [1 ]
Rudkjoebing, L. A. [2 ]
Bartko, E. [3 ]
机构：
[1] Gentofte Univ Hosp, Hellerup, Denmark
[2] Holbaek Cent Hosp, Holbaek, Denmark
[3] Allergy Clin, Dermatol & Allergy, Hellerup, Denmark
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
100324
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes
    Goralska, Joanna
    Sliwa, Agnieszka
    Gruca, Anna
    Razny, Urszula
    Chojnacka, Monika
    Polus, Anna
    Solnica, Bogdan
    Malczewska-Malec, Malgorzata
    ACTA BIOCHIMICA POLONICA, 2017, 64 (03) : 423 - 429
  • [42] The Prognostic Role of Glucagon-like Peptide-1 Receptor Agonist in Transthyretin Amyloid Cardiomyopathy
    Chi, Kuan Yu
    Borkowski, Pawel
    Song, Junmin
    Chang, Yu
    Chiang, Cho Han
    Nanna, Michele
    Sikand, Nikhil
    Gallegos, Cesia
    Nanna, Michael
    CIRCULATION, 2024, 150
  • [43] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    A. Faurschou
    F. K. Knop
    J. P. Thyssen
    C. Zachariae
    L. Skov
    T. Vilsbøll
    Acta Diabetologica, 2014, 51 : 147 - 150
  • [44] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    Faurschou, A.
    Knop, F. K.
    Thyssen, J. P.
    Zachariae, C.
    Skov, L.
    Vilsboll, T.
    ACTA DIABETOLOGICA, 2014, 51 (01) : 147 - 150
  • [45] Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2023, 15 (09) : 712 - 713
  • [46] Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide-1 Receptor Agonist
    Bucheit, John D.
    Pamulapati, Lauren G.
    Carter, Nicole
    Malloy, Kevin
    Dixon, Dave L.
    Sisson, Evan M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (01) : 10 - 18
  • [47] Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy
    Kobori, Toshiko
    Onishi, Yukiko
    Yoshida, Yoko
    Tahara, Tazu
    Kikuchi, Takako
    Kubota, Tetsuya
    Iwamoto, Masahiko
    Sawada, Tomonobu
    Kobayashi, Reo
    Fujiwara, Hiroaki
    Kasuga, Masato
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (06) : 767 - 773
  • [48] Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy
    Hong, Yeonhee
    Lee, Jong Han
    Jeong, Kwang Won
    Choi, Cheol Soo
    Jun, Hee-Sook
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2019, 10 (04) : 903 - 918
  • [49] Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
    Van Schaik, Jiska
    Begijn, Dominique G. A.
    Van Iersel, Laura
    Vergeer, Yvonne
    Hoving, Eelco W.
    Peeters, Babette
    Van Santen, Hanneke M.
    OBESITY FACTS, 2020, 13 (04) : 361 - 370
  • [50] The impact of glucagon-like peptide-1 receptor agonist on the gastric residue in upper endoscopy
    Abu-Freha, Naim
    Levi, Zohar
    Nevo-Shor, Anat
    Guterman, Revital
    Elhayany, Ruhama
    Yitzhak, Avraham
    Yovel, Dana Zelnik
    Cohen, Daniel L.
    Shirin, Haim
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 217
12345